CN Patent

CN103919717A — 一种酒石酸溴莫尼定眼用凝胶制剂及其制备方法和用途

Assigned to Tianjin University of Traditional Chinese Medicine · Expires 2014-07-16 · 12y expired

What this patent protects

本发明公开了一种酒石酸溴莫尼定眼用凝胶制剂，其组成为0.01-7重量份酒石酸溴莫尼定，0.1-12重量份凝胶材料，注射用水加至100重量份。所述眼用凝胶制剂可以延长药物在眼内的滞留时间，减少用药次数，提高生物利用度并减小毒副作用。本发明同时公开了一种酒石酸溴莫尼定眼用凝胶制剂的制备方法及其用途。

USPTO Abstract

本发明公开了一种酒石酸溴莫尼定眼用凝胶制剂，其组成为0.01-7重量份酒石酸溴莫尼定，0.1-12重量份凝胶材料，注射用水加至100重量份。所述眼用凝胶制剂可以延长药物在眼内的滞留时间，减少用药次数，提高生物利用度并减小毒副作用。本发明同时公开了一种酒石酸溴莫尼定眼用凝胶制剂的制备方法及其用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103919717A
Jurisdiction
CN
Classification
—
Expires
2014-07-16
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin University of Traditional Chinese Medicine
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.